AINIX
Price
$15.90
Change
+$0.13 (+0.82%)
Updated
Jan 14 closing price
Net Assets
264.44M
OAZIX
Price
$33.56
Change
+$0.23 (+0.69%)
Updated
Jan 14 closing price
Net Assets
14.5B
Interact to see
Advertisement

AINIX vs OAZIX

Header iconAINIX vs OAZIX Comparison
Open Charts AINIX vs OAZIXBanner chart's image
Ariel International Institutional
Price$15.90
Change+$0.13 (+0.82%)
VolumeN/A
Net Assets264.44M
Oakmark International R6
Price$33.56
Change+$0.23 (+0.69%)
VolumeN/A
Net Assets14.5B
AINIX vs OAZIX Comparison Chart in %
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
OAZIX has more cash in the bank: 14.5B vs. AINIX (264M). AINIX (2.26) and OAZIX (2.18) have matching dividends . AINIX was incepted earlier than OAZIX: AINIX (14 years) vs OAZIX (5 years). AINIX (1.01) is less costly to investors than OAZIX (0.75). AINIX is a more actively managed with annual turnover of: 89.00 vs. OAZIX (51.00). AINIX (1000000) and OAZIX (1000000) have matching initial minimum investment requirements. OAZIX annual gain was more profitable for investors over the last year : 40.55 vs. AINIX (19.15). OAZIX return over 5 years is better than : 37.37 vs. AINIX (23.35).
AINIXOAZIXAINIX / OAZIX
Total Expense Ratio0.910.75121%
Annual Report Gross Expense Ratio1.010.75135%
Fund Existence14 years5 years-
Gain YTD1.4033.61239%
Front LoadN/AN/A-
Min. Initial Investment10000001000000100%
Min. Initial Investment IRAN/AN/A-
Net Assets264M14.5B2%
Annual Yield % from dividends2.262.18104%
Returns for 1 year19.1540.5547%
Returns for 3 years28.6640.8370%
Returns for 5 years23.3537.3762%
Returns for 10 years65.73N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ERHSX14.950.12
+0.81%
Eaton Vance Worldwide Health Sci R
OSCCX20.890.09
+0.43%
Invesco Main Street Small Cap C
GPEIX10.300.03
+0.29%
Grandeur Peak Emerg Mkts Opps Instl
ANVIX27.04N/A
N/A
Virtus NFJ Large-Cap Value Fund Inst
JMGZX44.12-0.23
-0.52%
JPMorgan Mid Cap Growth R2